Matches in Wikidata for { <http://www.wikidata.org/entity/Q92718673> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q92718673 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q92718673 description "im März 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92718673 description "scientific article published on 27 March 2019" @default.
- Q92718673 description "wetenschappelijk artikel" @default.
- Q92718673 description "наукова стаття, опублікована 27 березня 2019" @default.
- Q92718673 name "Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies" @default.
- Q92718673 name "Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies" @default.
- Q92718673 type Item @default.
- Q92718673 label "Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies" @default.
- Q92718673 label "Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies" @default.
- Q92718673 prefLabel "Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies" @default.
- Q92718673 prefLabel "Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies" @default.
- Q92718673 P1433 Q92718673-6E8FE177-507D-458A-8DFC-43292E0EAA81 @default.
- Q92718673 P1476 Q92718673-F7D23CD6-EA44-48D1-BF96-5C1E7682B13C @default.
- Q92718673 P2093 Q92718673-09F37499-838A-46F2-823B-C71B54F78C65 @default.
- Q92718673 P2093 Q92718673-0F522604-BF47-48D0-B992-ACDD17CCCEF2 @default.
- Q92718673 P2093 Q92718673-1101638D-5F9F-4B6A-8994-DBB171F6B7DB @default.
- Q92718673 P2093 Q92718673-1D8F6B90-585D-4F3F-8CD1-7F4D54B44023 @default.
- Q92718673 P2093 Q92718673-1EE46931-0524-454B-A6D4-4BB9C9C330C5 @default.
- Q92718673 P2093 Q92718673-3D227F54-8B03-47E1-9DB0-9BED8316FC39 @default.
- Q92718673 P2093 Q92718673-59A0E204-CE2A-46D6-8FF4-9D99D7542419 @default.
- Q92718673 P2093 Q92718673-6327848E-A9ED-4C49-B7AE-CB1219DA6FB8 @default.
- Q92718673 P2093 Q92718673-75855AF7-0301-4CEB-8A5F-1B8B19887286 @default.
- Q92718673 P2093 Q92718673-900D5F90-9D1D-4019-BAD4-4A57364FF1F6 @default.
- Q92718673 P2093 Q92718673-962073EA-D504-4521-8CC7-D8CE4C4477EC @default.
- Q92718673 P2093 Q92718673-986752F0-78B4-478C-8FBE-D746864EC01A @default.
- Q92718673 P2093 Q92718673-ACCE44F5-EFC6-40A6-A57E-E8367F35765A @default.
- Q92718673 P2093 Q92718673-C3DB8439-F9FF-4178-92FC-35782ED0C493 @default.
- Q92718673 P2093 Q92718673-D63C0851-CA1B-43F0-9C78-9EAAE1BF938D @default.
- Q92718673 P2093 Q92718673-DDC5E69E-09BA-45DB-8495-6ACF395D0B07 @default.
- Q92718673 P2093 Q92718673-E0A7E1D3-15EA-41BF-A160-5AA248E7AC0C @default.
- Q92718673 P304 Q92718673-7101AE10-0A72-4809-9F8A-C7588F9D252C @default.
- Q92718673 P31 Q92718673-78562CBC-6322-4554-9223-DE24B790DB94 @default.
- Q92718673 P356 Q92718673-B877981F-897E-4F9E-87FB-DFF6B02FBDF4 @default.
- Q92718673 P433 Q92718673-532E231A-ABD4-4839-92C9-D326ED636957 @default.
- Q92718673 P478 Q92718673-ACAEA3AE-5E56-4BE4-9448-166D62551DD1 @default.
- Q92718673 P50 Q92718673-D1E59A52-42F2-4874-BE71-4F2D0F374D43 @default.
- Q92718673 P577 Q92718673-B7C9EBEF-5720-468E-B037-A22B906359F6 @default.
- Q92718673 P698 Q92718673-B5E75914-5CC7-4BDA-8F5C-ED1A1B993FFE @default.
- Q92718673 P356 J.BBMT.2019.03.025 @default.
- Q92718673 P698 30928627 @default.
- Q92718673 P1433 Q15754328 @default.
- Q92718673 P1476 "Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies" @default.
- Q92718673 P2093 "Alice Garnier" @default.
- Q92718673 P2093 "Alix Duquenne" @default.
- Q92718673 P2093 "Amandine Le Bourgeois" @default.
- Q92718673 P2093 "Anne Lok" @default.
- Q92718673 P2093 "Antoine Bonnet" @default.
- Q92718673 P2093 "Beatrice Mahe" @default.
- Q92718673 P2093 "Cyrille Touzeau" @default.
- Q92718673 P2093 "Louise Bouard" @default.
- Q92718673 P2093 "Marie C Bene" @default.
- Q92718673 P2093 "Nicolas Blin" @default.
- Q92718673 P2093 "Patrice Chevallier" @default.
- Q92718673 P2093 "Pierre Peterlin" @default.
- Q92718673 P2093 "Steven Le Gouill" @default.
- Q92718673 P2093 "Thierry Guillaume" @default.
- Q92718673 P2093 "Thomas Gastinne" @default.
- Q92718673 P2093 "Viviane Dubruille" @default.
- Q92718673 P2093 "Yannick Le Bris" @default.
- Q92718673 P304 "1465-1471" @default.
- Q92718673 P31 Q13442814 @default.
- Q92718673 P356 "10.1016/J.BBMT.2019.03.025" @default.
- Q92718673 P433 "7" @default.
- Q92718673 P478 "25" @default.
- Q92718673 P50 Q87734443 @default.
- Q92718673 P577 "2019-03-27T00:00:00Z" @default.
- Q92718673 P698 "30928627" @default.